CalciMedica
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06374797
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Chandler Regional Hospital, Chandler, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- CalciMedica, Inc.
- Registration Number
- NCT05171920
- Locations
- 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States
🇺🇸Methodist Hospital, Saint Paul, Minnesota, United States
🇺🇸JPS Health, Fort Worth, Texas, United States
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
- Conditions
- Systemic Inflammatory Response SyndromeAcute Pancreatitis
- Interventions
- Drug: CM-4620 Injectable Emulsion or CM-4620-IEOther: Placebo
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 216
- Registration Number
- NCT04681066
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸Methodist Hospital, Saint Louis Park, Minnesota, United States
🇺🇸Northshore University Hospital, Manhasset, New York, United States
A Study of Auxora in Patients With Critical COVID-19 Pneumonia
- Conditions
- Pneumonia
- Interventions
- Drug: CM4620-IE (Injectable Emulsion)Drug: Placebo
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT04661540
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
A Study of Auxora in Patients With Severe COVID-19 Pneumonia
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 284
- Registration Number
- NCT04345614
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸Baton Rouge General, Baton Rouge, Louisiana, United States
🇺🇸University of Southern California / LA County, Los Angeles, California, United States
A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT03709342
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
- Conditions
- Acute PancreatitisSystemic Inflammatory Response Syndrome
- Interventions
- Drug: CM4620 Injectable Emulsion (Low Dose)Drug: CM4620 Injectable Emulsion (High Dose)
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2021-12-07
- Lead Sponsor
- CalciMedica, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT03401190
- Locations
- 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States
🇺🇸Sinai-Grace Hospital (Wayne State), Detroit, Michigan, United States
🇺🇸Henry Ford Hospital, Detroit, Michigan, United States